Bayesian Modeling of Cancer Outcomes Using Genetic Variables Assisted by Pathological Imaging Data
- PMID: 39840672
- PMCID: PMC11774474
- DOI: 10.1002/sim.10350
Bayesian Modeling of Cancer Outcomes Using Genetic Variables Assisted by Pathological Imaging Data
Abstract
With the increasing maturity of genetic profiling, an essential and routine task in cancer research is to model disease outcomes/phenotypes using genetic variables. Many methods have been successfully developed. However, oftentimes, empirical performance is unsatisfactory because of a "lack of information." In cancer research and clinical practice, a source of information that is broadly available and highly cost-effective comes from pathological images, which are routinely collected for definitive diagnosis and staging. In this article, we consider a Bayesian approach for selecting relevant genetic variables and modeling their relationships with a cancer outcome/phenotype. We propose borrowing information from (manually curated, low-dimensional) pathological imaging features via reinforcing the same selection results for the cancer outcome and imaging features. We further develop a weighting strategy to accommodate the scenario where information borrowing may not be equally effective for all subjects. Computation is carefully examined. Simulations demonstrate competitive performance of the proposed approach. We analyze TCGA (The Cancer Genome Atlas) LUAD (lung adenocarcinoma) data, with overall survival and gene expressions being the outcome and genetic variables, respectively. Findings different from the alternatives and with sound properties are made.
Keywords: Bayesian estimation and selection; cancer modeling; genetic variables; information borrowing; pathological imaging data; weighting.
© 2025 John Wiley & Sons Ltd.
Similar articles
-
Pathological imaging-assisted cancer gene-environment interaction analysis.Biometrics. 2023 Dec;79(4):3883-3894. doi: 10.1111/biom.13873. Epub 2023 May 17. Biometrics. 2023. PMID: 37132273 Free PMC article.
-
Bayesian finite mixture of regression analysis for cancer based on histopathological imaging-environment interactions.Biostatistics. 2023 Apr 14;24(2):425-442. doi: 10.1093/biostatistics/kxab038. Biostatistics. 2023. PMID: 37057611 Free PMC article.
-
INTEGRATIVE ANALYSIS FOR LUNG ADENOCARCINOMA PREDICTS MORPHOLOGICAL FEATURES ASSOCIATED WITH GENETIC VARIATIONS.Pac Symp Biocomput. 2017;22:82-93. doi: 10.1142/9789813207813_0009. Pac Symp Biocomput. 2017. PMID: 27896964 Free PMC article.
-
Comparative Study of Bayesian Information Borrowing Methods in Oncology Clinical Trials.JCO Precis Oncol. 2022 Mar;6:e2100394. doi: 10.1200/PO.21.00394. JCO Precis Oncol. 2022. PMID: 35263169 Free PMC article. Review.
-
Adaptive Bayesian information borrowing methods for finding and optimizing subgroup-specific doses.Clin Trials. 2024 Jun;21(3):308-321. doi: 10.1177/17407745231212193. Epub 2024 Jan 19. Clin Trials. 2024. PMID: 38243401 Free PMC article. Review.
Cited by
-
Joint modeling of mixed outcomes using a rank-based sparse neural network.J Biomed Inform. 2025 Jul 5;169:104870. doi: 10.1016/j.jbi.2025.104870. Online ahead of print. J Biomed Inform. 2025. PMID: 40623577
References
-
- Makalic E, Schmidt DF. A Simple Sampler for the Horseshoe Estimator. IEEE Signal Processing Letters. 2016;23(1):179–182
-
- Ritter C, Tanner MA. Facilitating the Gibbs Sampler: The Gibbs Stopper and the Griddy-Gibbs Sampler. Journal of the American Statistical Association. 1992;87(419):861–868
-
- Barnard J, McCulloch R, Meng XL. Modeling covariance matrices in terms of standard deviations and correlations, with application to shrinkage. Statistica Sinica. 2000;10(4):1281–1311
-
- Zhu L, Huo Z, Ma T, Oesterreich S, Tseng GC. Bayesian indicator variable selection to incorporate hierarchical overlapping group structure in multi-omics applications. The Annals of Applied Statistics. 2019;13(4):2611 – 2636.
MeSH terms
Grants and funding
LinkOut - more resources
Medical